Miromatrix

Focus:

Type: Startup
Founded: 2009


Miromatrix Medical is engaged in the development of fully biological human organs and organ-derived biological products.

Leadership
Doris Taylor
Founder (not involved anymore)

Harald Ott
Founder (not involved anymore)
Concurrent Roles
Founder (IVIVA Medical)
Director (Massachusetts General Hospital)

Jeff Ross
CEO


Funding


Raised Capital
Year
Type
Offered / Sold Amount
Filings
Reported by Press*
Round
2019
2M USD
Grant
2018
15.7M USD
Series B
2018
15.72M USD
Series B
2015
23.78M USD
Series B
2012
5.3M USD
Venture Round
2011
2M USD
Venture Round
2013
16.1M USD
Venture Round
2014
6.1M USD
Venture Round
Known Investors
Name
Type
HQ
Other Relevant Investments
Venture Capital
United States
Corporation
United States
Private Equity
United States
Foundation
United States
Government Agency
United States
Angel
United States
Venture Capital
United States
*More data available at: [CB Insights] [CrunchBase] [PitchBook]

Products and
Technologies
Miroliver

Miromatrix is bioengineering transplantable livers based on our patented perfusion decellulization and recellularization technology to provide new options to the thousands of patients in need of a liver transplant. In our state-of-the-art facilities we are scaling to clinical sized implants and recently solved the vascular challenge that has limited tissue engineering and the promise of regenerative medicine, as described in our recent Nature Biomedical Engineering publication.

Images

Videos

Mirokidney

Miromatrix is bioengineering transplantable kidneys based on our patented perfusion decellulization and recellularization technology to provide new options to the thousands of patients who need a kidney transplant and to replace dialysis.

Images

Videos


Related
News